Company profilePharmaceutical#524 of 1,318 in Pakistan✓ No DRAP alerts

Maxitech Pharma (Pvt) Ltd. DML: 000851

Pharmaceutical company · 25 brands · 68 molecules

Ranked #8 of 14 companies in Ectoparasiticides; Scabicides

25 registered products 14 pharmaceutical brands 68 distinct molecules 0 DRAP alerts

Company overview

25
registered products
14
pharmaceutical brands
68
distinct molecules
3
therapeutic classes
0
DRAP alerts

Maxitech Pharma (Pvt) Ltd. DML: 000851 is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 25 product registrations across 68 distinct molecules. Its portfolio is concentrated in Ectoparasiticides; Scabicides and Anti-Infectives. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Artemether2 brands
Artemether.......................80Mg2 brands
Artemether ...... 40 Mg1 brand
Doxycycline ...... 100 Mg1 brand
Omeprazole ...... 40 Mg1 brand
Omeprazole1 brand
Cephalexin1 brand
Cephalexin ..................500Mg1 brand
Permethrin ...... 5 %1 brand

Therapeutic classes

Ectoparasiticides; Scabicides · 1Anti-Infectives · 1Antimycotics Systemic Use · 1

Conditions treated

General Infections · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official46 products · Rs 12 – Rs 11,775.86
DVAGO4 products · Rs 280 – Rs 807.5
Servaid1 products · Rs 172.5 – Rs 172.5
Median across source: Rs 383.31

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Get the full profile for Maxitech

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.